Results for "antegren"
Showing Results 1 - 15 for antegren
-
CCFA.org: Antegren® Phase III Clinical Trial Completed
... III trial to determine if Antegren® (natalizumab) induces remission in moderate ... to the continued development of Antegren® for both Crohn's disease and ...
www.ccfa.org -
Natalizumab - multiple sclerosis encyclopaedia
Multiple Sclerosis ... under the brand name Antegren by Elan and Biogen. ... Antegren(Natalizumab) Antegren/Promising Phase II Results. Elan to ...
www.mult-sclerosis.org -
ANTEGREN to be submitted for Approval for Crohn's Disease in Europe
Elan Corporation, plc and Biogen Idec today announced that they intend to submit to the European Medicines Agency an application for approval of ANTEGREN(R) ...
www.medicalnewstoday.com -
This Is MS | Unbiased Multiple Sclerosis Research, News, and Community
Antegren, recently renamed Tysabri, has received United States Food and Drug ... Even more promising is that Antegren hit all the secondary endpoints too (number ...
www.thisisms.com -
Biogen sees FDA approval of MS drug this month - The Boston Globe
Biogen Idec Inc. of Cambridge said it is in final discussions with the Food and Drug Administration about its new multiple sclerosis drug Antegren, and expects the ...
www.boston.com -
BioWorld Today
Despite a failed trial last year, Antegren now has garnered some positive Phase ... said, had a more stringent efficacy criteria for approval than Antegren did. ...
www.bioworld.com -
Report on Medicine
Antegren for the Chronic Treatment of Multiple Sclerosis ... Both studies suggest that Antegren may have a beneficial effect in suppressing ...
www.firelady40.com -
Tysabri or Antegren for Multiple Sclerosis, Antegran
Antegren is a, still experimental, drug used to treat MS. ... Aimspro Amantadine Amitriptyline Antegren Aricept Bee Sting Therapy Botox ...
www.mymultiplesclerosis.co.uk -
Tysabri (Natalizumab)
Information about Tysabri from Biogen Idec, covering its use to treat relapsing forms of multiple sclerosis (MS), medication guide, and more.
www.tysabri.com -
Change of habit might be key to drug's success - The Boston Globe
To turn its new multiple sclerosis treatment Antegren into a blockbuster drug with more than $1 billion in annual sales, Biogen Idec and its partner, Elan ...
www.boston.com -
This Is MS - Antegren One-Year Data Out: 66% Reduction in Relapses ...
Here is the story many of us have been holding our collective breaths for-- the one year data from the Antegren AFFIRM trial is now public. The results show a 66 ...
www.thisisms.com -
Antegren Data Delay Raises Eyebrows - TheStreet.com
The delay from Biogen Idec and Elan has been met with relative calm, but it raises questions. ... Will they reserve Antegren for use in patients who don't ...
www.thestreet.com -
Promising Antegren data ruffles Serono
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, companies and ...
www.bioportfolio.com -
Antegren - multiple sclerosis encyclopaedia
Multiple Sclerosis Encyclopaedia - Antegren ... Antegren. Brand name for the experimental MS drug Natalizumab manufactured by Elan and Biogen ...
www.mult-sclerosis.org -
Article: "Antegren Disappoints in Crohn's Disease Trials."
08/2003 "Antegren Disappoints in Crohn's Disease Trials." Credit Card Req'd - Free Trial. Academic Journal Articles, Magazine Articles, Newspaper Archives and more a
www.highbeam.com
| Next Results >> |
